Navigation Links
New study says probiotic use for infant colic is not effective in reducing symptoms
Date:4/17/2014

CHICAGO, IL, April 17, 2014-- Colic affects about one in five infants in the United States annually and accounts for numerous pediatric visits during the first several months after birth. Research into probiotic use for reduction of colic symptoms was showing promise; however, the April 1, 2014 issue of the British Medical Journal (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and Infant Colic," concluding that the use of the probiotic L reuteri for infant colic did not reduce crying or fussing in infants nor was it effective in improving infant sleep, functioning or quality of life. The results were no different for babies receiving breast milk or formula.

"The role of different intestinal microbes in producing or alleviating colic remains a subject of interest," says Joel Lavine, M.D., Ph.D., professor of pediatrics and chief of pediatric gastroenterology, hepatology and nutrition at Columbia University Medical Center. "Some studies have identified changes in the colonization that are associated with colic, although these changes have not been shown to be causative, and the specific kinds of bacteria potentially responsible have not been identified. Thus far, manipulation of gut colonization by probiotics remains an inexact science and conflicting evidence exists regarding the efficacy of probiotics in improving the problem."

Another under-discussed cause of colic symptoms, transient lactase deficiency (TLD), is known to be a cause of colic in about 38% of cases*. TLD is a temporary insufficiency of lactase enzyme, resulting in temporary digestive discomfort caused by the undigested lactose in breast milk or infant formula, often resulting in excessive crying and fussing, otherwise known as colic.

"Manipulation of bacterial populations in the gut may reduce the amount of gas produced by virtue of reducing lactose malabsorption," adds Dr. Lavine. "This problem of lactose malabsorption can be easily resolved by providing lactase to infants who are lacking, by way of commercially available infant drops."


'/>"/>

Contact: Danielle Maiello
dmaiello@rlapr.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Related medicine news :

1. Study IDs new cause of brain bleeding immediately after stroke
2. Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum
3. Celldexs Phase 1 study of CDX-1401 published in Science Translational Medicine
4. Study links severe sleep apnea to increased risk of stroke, cancer and death
5. Kessler Foundation scientists receive Biogen Idec grant to study actual reality in MS
6. UT Dallas study: Youth who fail to envision future commit more crimes
7. Study identifies a likely key driver of colorectal cancer development and progression
8. Study gives high marks to NC Pre-K program
9. Proteomics International biomarker study closer to a CDx test for diabetic kidney disease
10. Study links domestic abuse to mental health problems in new mothers
11. Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: